Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: 2021-03-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,910,194
Percent of class
4.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-014756
Form type
SC 13G/A
Filer
ETF MANAGERS GROUP, LLC
CIK
CIK 1645173
Filed
Mar 11, 2021
Reporting period
Mar 09, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub